Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Immunogenetics associated with severe coccidioidomycosis
Amy P. Hsu, … , Michail S. Lionakis, Steven M. Holland
Amy P. Hsu, … , Michail S. Lionakis, Steven M. Holland
Published September 27, 2022
Citation Information: JCI Insight. 2022;7(22):e159491. https://doi.org/10.1172/jci.insight.159491.
View: Text | PDF
Research Article Genetics Infectious disease

Immunogenetics associated with severe coccidioidomycosis

  • Text
  • PDF
Abstract

Disseminated coccidioidomycosis (DCM) is caused by Coccidioides, pathogenic fungi endemic to the southwestern United States and Mexico. Illness occurs in approximately 30% of those infected, less than 1% of whom develop disseminated disease. To address why some individuals allow dissemination, we enrolled patients with DCM and performed whole-exome sequencing. In an exploratory set of 67 patients with DCM, 2 had haploinsufficient STAT3 mutations, and defects in β-glucan sensing and response were seen in 34 of 67 cases. Damaging CLEC7A and PLCG2 variants were associated with impaired production of β-glucan–stimulated TNF-α from PBMCs compared with healthy controls. Using ancestry-matched controls, damaging CLEC7A and PLCG2 variants were overrepresented in DCM, including CLEC7A Y238* and PLCG2 R268W. A validation cohort of 111 patients with DCM confirmed the PLCG2 R268W, CLEC7A I223S, and CLEC7A Y238* variants. Stimulation with a DECTIN-1 agonist induced DUOX1/DUOXA1–derived hydrogen peroxide [H2O2] in transfected cells. Heterozygous DUOX1 or DUOXA1 variants that impaired H2O2 production were overrepresented in discovery and validation cohorts. Patients with DCM have impaired β-glucan sensing or response affecting TNF-α and H2O2 production. Impaired Coccidioides recognition and decreased cellular response are associated with disseminated coccidioidomycosis.

Authors

Amy P. Hsu, Agnieszka Korzeniowska, Cynthia C. Aguilar, Jingwen Gu, Eric Karlins, Andrew J. Oler, Gang Chen, Glennys V. Reynoso, Joie Davis, Alexandria Chaput, Tao Peng, Ling Sun, Justin B. Lack, Derek J. Bays, Ethan R. Stewart, Sarah E. Waldman, Daniel A. Powell, Fariba M. Donovan, Jigar V. Desai, Nima Pouladi, Debra A. Long Priel, Daisuke Yamanaka, Sergio D. Rosenzweig, Julie E. Niemela, Jennifer Stoddard, Alexandra F. Freeman, Christa S. Zerbe, Douglas B. Kuhns, Yves A. Lussier, Kenneth N. Olivier, Richard C. Boucher, Heather D. Hickman, Jeffrey Frelinger, Joshua Fierer, Lisa F. Shubitz, Thomas L. Leto, George R. Thompson III, John N. Galgiani, Michail S. Lionakis, Steven M. Holland

×

Figure 2

DECTIN-1 signaling drives H2O2 production by DUOX1 and DUOXA1 in HEK cells.

Options: View larger image (or click on image) Download as PowerPoint
DECTIN-1 signaling drives H2O2 production by DUOX1 and DUOXA1 in HEK cel...
(A) DECTIN-1–activated PLCγ2 releases intracellular Ca++, which activates the EF-hand domains of DUOX1, leading to H2O2 production. DUOX1 and DUOXA1 patient variants are highlighted by yellow stars. (B) DUOX1 variants identified in patients with DCM were transfected into HEK Flp-In cells stably expressing WT DUOXA1. Cells were stimulated with ionomycin, and H2O2 production was measured for 60 minutes. Results are the average of triplicate wells presented as the ratio of H2O2 production by variant or WT; each dot represents the average of triplicate wells from a unique experiment. ****P < 0.0001 by ordinary 1-way ANOVA and Dunnett’s multiple comparisons test. Western blot showing decreased protein abundance of several DUOX1 variants after transfection. (C) DUOXA1 variants, identified in patients with DCM, transfected into HEK Flp-In cells stably expressing DUOX1. Measured as in B. P = 0.016 by ordinary 1-way ANOVA and Dunnett’s multiple comparisons test. (D) Hydrogen peroxide production in HEK cells transfected with WT or patient variant DUOX1, DUOXA1, or DECTIN1, or lacking PLCG2 constructs. Results are the average of triplicate wells presented as the ratio of H2O2 production by variant/WT; each dot represents a unique experiment. ****P < 0.0001 using ordinary 1-way ANOVA and Dunnett’s multiple comparisons test.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts